ATE258176T1 - Neue azabicyclo derivate und ihre verwendung - Google Patents

Neue azabicyclo derivate und ihre verwendung

Info

Publication number
ATE258176T1
ATE258176T1 AT00901487T AT00901487T ATE258176T1 AT E258176 T1 ATE258176 T1 AT E258176T1 AT 00901487 T AT00901487 T AT 00901487T AT 00901487 T AT00901487 T AT 00901487T AT E258176 T1 ATE258176 T1 AT E258176T1
Authority
AT
Austria
Prior art keywords
derivatives
azabicyclo derivatives
new
new azabicyclo
labelled
Prior art date
Application number
AT00901487T
Other languages
English (en)
Inventor
Dan Peters
Joergen Scheel-Krueger
Elsebet Oestergaard Nielsen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of ATE258176T1 publication Critical patent/ATE258176T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT00901487T 1999-01-28 2000-01-28 Neue azabicyclo derivate und ihre verwendung ATE258176T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA199900106 1999-01-28
DKPA199900950 1999-07-01
PCT/DK2000/000038 WO2000044746A1 (en) 1999-01-28 2000-01-28 Novel azabicyclo derivatives and their use

Publications (1)

Publication Number Publication Date
ATE258176T1 true ATE258176T1 (de) 2004-02-15

Family

ID=26063317

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00901487T ATE258176T1 (de) 1999-01-28 2000-01-28 Neue azabicyclo derivate und ihre verwendung

Country Status (6)

Country Link
US (1) US6617459B2 (de)
EP (1) EP1149095B1 (de)
AT (1) ATE258176T1 (de)
AU (1) AU2278700A (de)
DE (1) DE60007841T2 (de)
WO (1) WO2000044746A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1358177B1 (de) * 2000-10-13 2006-08-02 NeuroSearch A/S Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
US20030080191A1 (en) 2001-10-26 2003-05-01 Allen Lubow Method and apparatus for applying bar code information to products during production
WO2003052681A1 (en) 2001-12-17 2003-06-26 International Barcode Corporation Double-sided bar code doubling as a single bar code
EP1768705A4 (de) * 2004-05-07 2008-01-23 Univ California System Verfahren für den nachweis von alzheimer und anderen formen von demenz sowie zur messung ihrer progression
CA2577084A1 (en) 2004-08-25 2006-03-02 Olivier Bezencon Bicyclononene derivatives as renin inhibitors
MX2007007260A (es) * 2004-12-22 2007-08-14 Neurosearch As Nuevos derivados de azabiciclo sustituidos con naftilo y su uso como inhibidores de la recaptacion del neurotransmisor de monoamina.
AU2006233884A1 (en) * 2005-04-08 2006-10-19 Neurosearch A/S (+) - and (-) -8-alkyl-3-(trifluoralkylsulfonyloxy)-8-azabicycl (3.2.1.)oct-2-ene
EP1728520A1 (de) * 2005-05-04 2006-12-06 Charité - Universitätsmedizin Berlin Verwendung von spezifisch an das Serotonin-Transport-Protein (SERT) bindenden Radiopharmaka zur Herstellung eines Diagnostikums zur Untersuchung von Kopfschmerzerkrankungen
WO2006117218A2 (en) * 2005-05-04 2006-11-09 Charite Universitätsmedizin - Berlin Serotonin-transport-protein binding radiopharmaceutical for the production of a diagnostic medicament for the diagnosis of headache
US8114382B2 (en) * 2006-12-11 2012-02-14 General Electric Company Myelin detection using benzofuran derivatives
AU2010286595A1 (en) * 2009-08-28 2012-02-23 NEBA Health, LLC. Systems and methods to identify a subgroup of ADHD at higher risk for complicating conditions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3509161A (en) * 1967-07-10 1970-04-28 Boehringer & Soehne Gmbh 3-phenyl-granatene-(2)-derivatives
GB9507203D0 (en) * 1995-04-07 1995-05-31 Smithkline Beecham Plc Novel compounds
HUP9802433A3 (en) * 1995-10-13 2000-03-28 Neurosearch As 8-azabicyclo[3.2.1]oct-2-ene derivatives, their preparation and use
GB9706222D0 (en) * 1997-03-26 1997-05-14 Zeneca Ltd Bicyclic amine derivatives
KR100589872B1 (ko) * 1997-05-30 2006-06-15 뉴로서치 에이/에스 8-아자비사이클로(3,2,1)옥트-2-엔 유도체 및 이의 제조방법
JP2002502383A (ja) * 1997-05-30 2002-01-22 ニューロサーアチ・アクティーゼルスカブ ニコチンＡＣｈレセプターに於けるコリン作動性リガンドとしての９−アザビシクロ（３．３．１）ノン−２−エン及びノナン誘導体
JP2002501921A (ja) * 1998-01-28 2002-01-22 ニューロサーチ、アクティーゼルスカブ 標識された形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体及び標識された及び標識されていない形での８−アザビシクロ［３．２．１］オクト−２−エン誘導体の使用方法

Also Published As

Publication number Publication date
DE60007841T2 (de) 2004-07-08
EP1149095B1 (de) 2004-01-21
EP1149095A1 (de) 2001-10-31
AU2278700A (en) 2000-08-18
DE60007841D1 (de) 2004-02-26
US6617459B2 (en) 2003-09-09
US20010047028A1 (en) 2001-11-29
WO2000044746A1 (en) 2000-08-03

Similar Documents

Publication Publication Date Title
HUP0102992A3 (en) Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis
CA2381819A1 (en) New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
DE60042066D1 (de) Chimärische dr4 antikörper und ihre verwendung
PT1053256E (pt) Anticorpos para o receptor de morte 4 (dr4) e utilizações destes
EA200200530A1 (ru) Гетероциклические замещенные пиразолоны
IL146631A0 (en) Diagnostics and therapeutics for cardiovascular disorders
IL127558A0 (en) Hepatocyte growth factor receptor agonists and uses thereof
BR1100538A (pt) Antagonistas de vasopressina benzazepina tricìclicos
DE69528823D1 (en) Morpholinwirkstoffvorläufer als tachykininreceptorantagonisten
ATE381560T1 (de) Neue benzazepine und ähnliche heterocyclische derivate,die als orexin rezeptor antagonisten geeignet sind
NO20022655L (no) &lt;Beta&gt;-2-adrenerge reseptoragonister
YU20600A (sh) Nova upotreba antagonista 5-ht3 receptora
EA199700156A1 (ru) Производные индола как антагонисты рецептора 5-нт
DE60007841D1 (de) Neue azabicyclo derivate und ihre verwendung
MXPA03009644A (es) Grupos azabiciclicos sustituidos para el tratamiento de enfermedades.
IL159527A0 (en) Human dr4 antibodies and uses thereof
BG105445A (en) Phermaceutical agents for the treatment of parkinson&#39;s disease, adhd and microadenomas
MXPA04001089A (es) 5-arilsulfonil indoles que tienen afinidad por el receptor de 5-ht.
CO5460266A1 (es) Novedosos analogos de la somatostatina
CA2263961A1 (en) Cocaine receptor binding ligands
MY133390A (en) Azabicyclic 5ht1 receptor ligands
ATE453627T1 (de) Herstellung von verbindungen zur bestimmung der hypoxie
WO1999038866A8 (en) 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled form and use of 8-azabicyclo[3.2.1]oct-2-ene derivatives in labelled and unlabelled form
YU26001A (sh) Derivati ureidopiperidina kao selektivni antagonisti ljudskih nk3 receptora
WO2001011085A3 (en) Bdnf polymorphism and association with bipolar disorder

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties